We are entering an era of disruption driven by artificial intelligence and modern technology that is exponential in scale to anything we have ever experienced.
Indiana’s largest life sciences companies and research universities are working to make the state an international leader in chemistry innovation — and they’re ready to launch the first step in a plan called Catalyze Indiana.
The professionals who can frame the right questions, exercise creativity and judgment in ambiguous situations, and communicate effectively across teams are more valuable, not less.
Under the new laws, data centers will have to pay local governments a portion of the tax cuts they receive and Carmel and Fishers will have to end caps on rental properties.
Speakers at IBJ’s Technology Power Breakfast, including Purdue University President Mung Chiang, talked about the changes that artificial intelligence is bringing and what people can do to be ready.
Indianapolis is home to the construction management and general contracting firm’s second-largest office, after its corporate headquarters in Cincinnati.
The Indy Chamber is revving up the campaign with a call for people to share personal stories of ambition, growth and resilience in the context of living in Indianapolis and its surrounding counties
Tim Coleman has held positions within information technology at Lilly in research and development, sales and marketing, manufacturing, and human resources.
Data from the Indiana Business Research Center reveals that only 61% of Indiana college students who earn a bachelor’s degree are still employed in the state one year later. That number drops to a staggering 55% after five years.
Creating opportunities for internships is an essential component of preparing Indiana students for the world of work as well as increasing the chances that we retain these individuals in our state post-graduation.
While hard decisions remain for IPS, HEA 1423 creates the opportunity for a restructured school system, acknowledging that the status quo was no longer acceptable.
Low founded seven companies based on intellectual property developed at Purdue, including Endocyte Inc., which he sold to Novartis Inc. in 2018 for $2.1 billion.
